KRRO is trading 5.1% up at $14.77, extending its strong multi-session rebound over the past week.

  • The stock's gains come as broader U.S. indices trade lower today.
  • There are no fresh company-specific headlines, earnings, FDA actions, or major analyst calls, suggesting today's strength is technical or flow-driven following recent gains.